Intensity Therapeutics Says Breast Cancer Treatment Showed T

-- Intensity Therapeutics said Friday efficacy data from its phase 2 trial of INT230-6 in people with early-stage breast cancer showed a high order of necrosis in presurgical breast cancer tumors in...

Related Keywords

Ottawa , Ontario , Canada , Bristol Myers Squibb , Merck Sharpe Dohme , Ontario Institute Of Cancer Research , Ottawa Hospital Research Institute , Intensity Therapeutics Inc , Intensity Therapeutics , Merck Sharpe , Ontario Institute , Cancer Research , Markets ,